BDSX
BIODESIX INC
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$29.20
+1.35%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.53x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 33.69x
- Price / sales
- 2.99x
- Price / cash flow
- -15.54x
Enterprise value
- Enterprise value
- $349.9M
- EV / sales
- 3.40x
- EV / EBITDA
- -24.50x
- EV / EBIT
- -16.99x
- Market cap
- $308.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026